Single-Molecule Phenotype Analysis
AssigneeThe Trustees of the California State University
InventorsKambiz Hamadani, James Harrison Cate Doudna, Susan Marqusee
Life of this patent
Estimating the term…
Abstract
Aspects of the present disclosure include methods of producing modified polypeptides and modified polypeptide-ribosome or polypeptide-mRNA complexes, and methods of screening polynucleotide and polypeptide libraries. The present disclosure also provides polypeptide libraries useful in screening for single molecule phenotypes. Also provided are kits useful for producing polypeptides capable of being modified using methods disclosed herein.
Claims22
1-59. (canceled)
A method of producing modified polypeptides suitable for structural and functional single molecule screening applications, the method comprising:
- carrying out in vitro cell-free translation of a polynucleotide in the presence of an unnatural amino acid,
- incorporating the unnatural amino acid at genetically-encoded positions in the target polypedtide, wherein incorporating comprises an incorporation efficiency, an incorporation specificity and a post-incorporation stability,
- generating between 5 and 500 picomoles of a polypeptide comprising the unnatural amino acid incorporated at genetically-encoded positions in the target polypeptide, wherein the unnatural amino acid comprises a reactive group, wherein the incorporation efficiency of the unnatural amino acid incorporation events at each of the genetically-encoded positions in the target polypeptide is at least about 10:1, as compared to incorporation of a natural an amino acid into a target position in the target polypeptide, wherein the incorporation specificity of the unnatural amino-acid incorporation events for the particular genetically-encoded positions in the target polypeptide is at least about 10:1, as compared to incorporation of the unnatural amino acid into a non-target polypeptide or a non-target position in the target polypeptide, wherein the post-incorporation stability of the unnatural amino acid reactive group is at least about 10:1, as the combination of the incorporation efficiency, the incorporation specificity, and the post-incorporation stability renders target purification unnecessary for single molecule screening applications;
- and
- modifying the unnatural amino acid by cycloaddition of a heterologous moiety thereby producing a modified polypeptide comprising the heterologous moiety, wherein modifying is quantified using a labeling efficiency.
A kit, comprising:
- a reagent for carrying out a cell-free in vitro translation reaction in the presence of an unnatural amino acid wherein the unnatural amino acid comprises a reactive group;
- and
- a reagent for carrying out a cycloaddition reaction useful in covalently attaching a heterologous moiety comprising a fluorophore to the reactive group on the unnatural amino acid.
Dependencies are inferred from the claim text.